These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 31657270)

  • 1. Early and Late Effects of Cardiac Resynchronization Therapy in Adult Congenital Heart Disease.
    Yin Y; Dimopoulos K; Shimada E; Lascelles K; Griffiths S; Wong T; Gatzoulis MA; Babu-Narayan SV; Li W
    J Am Heart Assoc; 2019 Nov; 8(21):e012744. PubMed ID: 31657270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac resynchronization therapy in patients with congenital heart disease and systemic right ventricle.
    Jacquemart E; Combes N; Duthoit G; Bessière F; Ladouceur M; Iserin L; Laredo M; Bredy C; Maltret A; Di Filippo S; Hascoët S; Pasquié JL; Marijon E; Waldmann V
    Heart Rhythm; 2022 Apr; 19(4):658-666. PubMed ID: 34863963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Term Outcomes of Cardiac Resynchronization Therapy in Patients With Repaired Tetralogy of Fallot: A Multicenter Study.
    Ramdat Misier NL; Moore JP; Nguyen HH; Lloyd MS; Dubin AM; Mah DY; Czosek RJ; Khairy P; Chang PM; Nielsen JC; Aydin A; Pilcher TA; O'Leary ET; Shivkumar K; de Groot NMS
    Circ Arrhythm Electrophysiol; 2024 Mar; 17(3):e012363. PubMed ID: 38344811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Term Outcome of Patients With Congenital Heart Disease Undergoing Cardiac Resynchronization Therapy.
    Kubuš P; Rubáčková Popelová J; Kovanda J; Sedláček K; Janoušek J
    J Am Heart Assoc; 2021 Mar; 10(6):e018302. PubMed ID: 33719495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of Left Ventricular Size and Sex on Outcome of Cardiac Resynchronization Therapy Among Patients With a Narrow QRS Duration in the EchoCRT Trial.
    Varma N; Sogaard P; Bax JJ; Abraham WT; Borer JS; Dickstein K; Singh JP; Gras D; Holzmeister J; Brugada J; Ruschitzka F
    J Am Heart Assoc; 2018 May; 7(11):. PubMed ID: 29807890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Echocardiographic predictors of reverse remodeling after cardiac resynchronization therapy and subsequent events.
    Park JH; Negishi K; Grimm RA; Popovic Z; Stanton T; Wilkoff BL; Marwick TH
    Circ Cardiovasc Imaging; 2013 Nov; 6(6):864-72. PubMed ID: 24084489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of cardiac resynchronization therapy in congenital heart disease: A meta-analysis and systematic review.
    Tokavanich N; Mongkonsritragoon W; Sattawatthamrong S; Techasatian W; Siranart N; Prasitlumkum N; Navaravong L; Chokesuwattanaskul R
    J Cardiovasc Electrophysiol; 2024 Feb; 35(2):249-257. PubMed ID: 38065836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. QRS fusion complex analysis using wave interference to predict reverse remodeling during cardiac resynchronization therapy.
    Sweeney MO; Hellkamp AS; van Bommel RJ; Schalij MJ; Borleffs CJ; Bax JJ
    Heart Rhythm; 2014 May; 11(5):806-13. PubMed ID: 24462523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial.
    Daubert C; Gold MR; Abraham WT; Ghio S; Hassager C; Goode G; Szili-Török T; Linde C;
    J Am Coll Cardiol; 2009 Nov; 54(20):1837-46. PubMed ID: 19800193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The benefit of upgrading chronically right ventricle-paced heart failure patients to resynchronization therapy demonstrated by strain rate imaging.
    Eldadah ZA; Rosen B; Hay I; Edvardsen T; Jayam V; Dickfeld T; Meininger GR; Judge DP; Hare J; Lima JB; Calkins H; Berger RD
    Heart Rhythm; 2006 Apr; 3(4):435-42. PubMed ID: 16567291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cardiac resynchronization therapy on reverse remodeling and relation to outcome: multicenter automatic defibrillator implantation trial: cardiac resynchronization therapy.
    Solomon SD; Foster E; Bourgoun M; Shah A; Viloria E; Brown MW; Hall WJ; Pfeffer MA; Moss AJ;
    Circulation; 2010 Sep; 122(10):985-92. PubMed ID: 20733097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. His-Optimized Cardiac Resynchronization Therapy to Maximize Electrical Resynchronization: A Feasibility Study.
    Vijayaraman P; Herweg B; Ellenbogen KA; Gajek J
    Circ Arrhythm Electrophysiol; 2019 Feb; 12(2):e006934. PubMed ID: 30681348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 16 Years of Cardiac Resynchronization Pacing Among Congenital Heart Disease Patients: Direct Contractility (dP/dt-max) Screening When the Guidelines Do Not Apply.
    Karpawich PP; Bansal N; Samuel S; Sanil Y; Zelin K
    JACC Clin Electrophysiol; 2017 Aug; 3(8):830-841. PubMed ID: 29759779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of right ventriclular systolic function prior to cardiac resynchronization therapy: Does it make any difference?
    Abdelhamid MA; Ghanem MT; Abdelmotaleb AM
    Indian Heart J; 2017; 69(6):731-735. PubMed ID: 29174250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of QRS complex duration and morphology on left ventricular reverse remodelling and left ventricular function improvement after cardiac resynchronization therapy.
    van der Bijl P; Khidir M; Leung M; Mertens B; Ajmone Marsan N; Delgado V; Bax JJ
    Eur J Heart Fail; 2017 Sep; 19(9):1145-1151. PubMed ID: 28176418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of QRS duration and morphology on cardiac resynchronization therapy outcomes in mild heart failure: results from the Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE) study.
    Gold MR; Thébault C; Linde C; Abraham WT; Gerritse B; Ghio S; St John Sutton M; Daubert JC
    Circulation; 2012 Aug; 126(7):822-9. PubMed ID: 22781424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Cardiac Resynchronization Therapy With Change in Left Ventricular Ejection Fraction in Patients With Chemotherapy-Induced Cardiomyopathy.
    Singh JP; Solomon SD; Fradley MG; Barac A; Kremer KA; Beck CA; Brown MW; McNitt S; Schleede S; Zareba W; Goldenberg I; Kutyifa V;
    JAMA; 2019 Nov; 322(18):1799-1805. PubMed ID: 31714987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reverse electrical remodeling by cardiac resynchronization therapy: prevalence and clinical impact.
    Sebag FA; Martins RP; Defaye P; Hidden-Lucet F; Mabo P; Daubert JC; Leclercq C
    J Cardiovasc Electrophysiol; 2012 Nov; 23(11):1219-27. PubMed ID: 22697464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paced left ventricular QRS width and ECG parameters predict outcomes after cardiac resynchronization therapy: PROSPECT-ECG substudy.
    Hsing JM; Selzman KA; Leclercq C; Pires LA; McLaughlin MG; McRae SE; Peterson BJ; Zimetbaum PJ
    Circ Arrhythm Electrophysiol; 2011 Dec; 4(6):851-7. PubMed ID: 21956038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resynchronizing Right and Left Ventricles With Right Bundle Branch Block in the Congenital Heart Disease Population.
    Mah DY; O'Leary ET; Harrild DM; Porras D; Gurvitz M; Marx G; Rathod RH; Fynn-Thompson F
    JACC Clin Electrophysiol; 2020 Dec; 6(14):1762-1772. PubMed ID: 33357572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.